ROSE-Longitudinal Assessment With Neuroimaging

Description

The investigators will perform follow-up on 250 of 500 cases recruited into the ROSE study of cases with deep and lobar intracerebral hemorrhage to perform advanced neuroimaging at 12-24 months post stroke, and evaluations of motor and cognitive function at baseline, 6 months after baseline, and 12 months after baseline to determine predictors of recovery, progressive cognitive or functional impairment. The investigators propose to leverage the recruitment, DNA, RNA-seq and baseline advanced neuroimaging cohort of ROSE to obtain long-term neuroimaging and identical assessments longitudinally to address critical questions regarding the progressive decline of patients 12 to 24 months post intracerebral hemorrhage (ICH) with long term cognitive follow-up to 36 months on average. This proposal would represent the largest, and longest advanced neuroimaging and RNA-sequencing evaluation after ICH to date.

Conditions

Intracerebral Hemorrhage

Study Overview

Study Details

Study overview

The investigators will perform follow-up on 250 of 500 cases recruited into the ROSE study of cases with deep and lobar intracerebral hemorrhage to perform advanced neuroimaging at 12-24 months post stroke, and evaluations of motor and cognitive function at baseline, 6 months after baseline, and 12 months after baseline to determine predictors of recovery, progressive cognitive or functional impairment. The investigators propose to leverage the recruitment, DNA, RNA-seq and baseline advanced neuroimaging cohort of ROSE to obtain long-term neuroimaging and identical assessments longitudinally to address critical questions regarding the progressive decline of patients 12 to 24 months post intracerebral hemorrhage (ICH) with long term cognitive follow-up to 36 months on average. This proposal would represent the largest, and longest advanced neuroimaging and RNA-sequencing evaluation after ICH to date.

Recovery and Outcomes From Stroke-Longitudinal Assessment With Neuroimaging

ROSE-Longitudinal Assessment With Neuroimaging

Condition
Intracerebral Hemorrhage
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Illinois Chicago, Chicago, Illinois, United States, 60612

Louisville

Baptist Health Louisville, Louisville, Kentucky, United States, 40207

Baltimore

University of Maryland, Baltimore, Maryland, United States, 21201

New York

Columbia University, New York, New York, United States, 10032

Durham

Duke University, Durham, North Carolina, United States, 27710

Cincinnati

University of Cincinnati, Cincinnati, Ohio, United States, 45267

Houston

Houston Methodist, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or greater, fulfillment of the criteria for Deep, Subcortical or Lobar Intracerebral Hemorrhage
  • * No evidence of trauma, vascular malformation or aneurysm, or brain tumor as a cause of ICH.
  • * Ability of the patient or legal representative to provide informed consent
  • * Brainstem or Cerebellar ICH
  • * Patients Severely Affected by the ICH, Early Mortality, Hospice, or Withdraw of Care NOT eligible for ROS

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Cincinnati,

Daniel Woo, MD, MS, PRINCIPAL_INVESTIGATOR, University of Cincinnati

Study Record Dates

2025-09-30